As proof of concept, we first demonstrated the ability of AZ106 (10 μM) to prevent endothelial dysfunction in intact rat aorta in response to IL‐1β, an inflammatory mediator upregulated during sepsis. Here, IL1B is linked to endothelial dysfunction.